Figure 7.
Vascular remodeling and angiogenic activity during murine BOS is attributable to CXCR2/CXCR2 ligand biology. (A) Representative CMP assay for vascular remodeling of tracheal-derived angiogenic activity from allografts with ex vivo–administered anti-CXCR2 Ab compared with control Ab. Magnification, ×20. (B) FACS analysis of MECA-32 from allografts treated with in vivo anti-CXCR2 Ab compared with control Ab.